About this resource:
Source: National Institutes of Health
Last Reviewed: March 2022
Workgroups: HIV Workgroup
In this report, the Panel on Treatment of HIV in Pregnancy and Prevention of Perinatal Transmission (the Panel) provides recommendations on HIV screening in pregnancy, the treatment of pregnant people with HIV, and the use of antiretroviral (ARV) drugs to prevent perinatal (vertical) transmission of HIV from mother to infant.
Since some ART drugs have not been sufficiently studied for evidence of harm to mothers and infants, the Panel uses a graded approach to recommendations — noting, for example, when there is insufficient data to recommend a medicine for pregnant people.
In the latest version of the recommendations, the Panel updated and added to the guidelines to include new data and publications in several sections.
Objectives related to this resource (1)
U.S. Department of Health and Human Services, Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. (2022). Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Retrieved from https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines